SC 57461
CAS No. 423169-68-0
SC 57461( SC 57461A )
Catalog No. M14440 CAS No. 423169-68-0
A potent and selective inhibitor of LTA4 hydrolase (LTA4H) with IC50/Ki of 5 nM/23 nM; inhibits calcium ionophore-induced LTB(4) production in human whole blood (IC50=49 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 33 | In Stock |
|
| 5MG | 55 | In Stock |
|
| 10MG | 88 | In Stock |
|
| 25MG | 179 | In Stock |
|
| 50MG | 275 | In Stock |
|
| 100MG | 403 | In Stock |
|
| 200MG | 573 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSC 57461
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent and selective inhibitor of LTA4 hydrolase (LTA4H) with IC50/Ki of 5 nM/23 nM; inhibits calcium ionophore-induced LTB(4) production in human whole blood (IC50=49 nM).
-
DescriptionA potent and selective inhibitor of LTA4 hydrolase (LTA4H) with IC50/Ki of 5 nM/23 nM; inhibits calcium ionophore-induced LTB(4) production in human whole blood (IC50=49 nM), no effect on production of the cyclooxygenase metabolite thromboxane B(2); orally active in vivo.Irritable Bowel Syndrome Discontinued.
-
In Vitro——
-
In VivoAnimal Model:Fasted CD rats Dosage:0.01, 0.1, 1, and 10 mg/kg Administration:Orally administered Result:The ED50 values were 0.2 mg/kg at 1.0 h and 0.8 mg/kg at 3.0 h. A single dose of 10 mg/kg blocked LTB4 production 79% at 6 h, 67% at 18 h, and 44% at 24 h.
-
SynonymsSC 57461A
-
PathwayOthers
-
TargetOther Targets
-
RecptorOther Targets
-
Research AreaOther Indications
-
IndicationIrritable Bowel Syndrome
Chemical Information
-
CAS Number423169-68-0
-
Formula Weight363.88
-
Molecular FormulaC20H25NO3.HCl
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (687.04 mM)
-
SMILESO=C(O)CCN(C)CCCOC1=CC=C(CC2=CC=CC=C2)C=C1
-
Chemical Name3-((3-(4-benzylphenoxy)propyl)(methyl)amino)propanoic acid hydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Askonas LJ, et al. J Pharmacol Exp Ther. 2002 Feb;300(2):577-82.
2. Kachur JF, et al. J Pharmacol Exp Ther. 2002 Feb;300(2):583-7.
3. Penning TD, et al. J Med Chem. 2002 Aug 1;45(16):3482-90.
molnova catalog
related products
-
Nonapeptide-1
Nonapeptide-1 can inhibit the synthesis of melanin which makes it of interest for treating certain skin conditions.?
-
Quercetin 3,5,3-trim...
Quercetin 3,5,3'-trimethyl ether is a natural product.
-
TIC10
TIC10 inactivates Akt and ERK to induce TRAIL through Foxo3a, possesses superior drug properties: delivery across the blood-brain barrier, superior stability and improved pharmacokinetics. Phase 1/2.
Cart
sales@molnova.com